Manjiri M. Bakre

4, Raja Ram Mohan Roy Road, Aanand Towers, 2nd Floor
Bengaluru, KA 560027, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Biomarker-based risk stratification for predicting late recurrence and benefit of extended endocrine therapy: A secondary analysis of the IDEAL trial.

Biomarker-based risk stratification for predicting late recurrence and benefit of extended endocrine therapy: A secondary analysis of the IDEAL trial.

Journal: Breast (Edinburgh, Scotland)

Published: May 11, 2026

CanAssist Breast Risk Stratification in Multifocal/Multicentric Breast Cancer: To Test Each Focus or Not?

CanAssist Breast Risk Stratification in Multifocal/Multicentric Breast Cancer: To Test Each Focus or Not?

Journal: Archives of pathology & laboratory medicine

Published: April 08, 2026

CanAssist Breast Provides Additional Insightful Prognostic Information in Retrospective, Pooled Secondary Analysis in Clinically Low/ High-Risk Patients With HR+/HER2- EBC.

CanAssist Breast Provides Additional Insightful Prognostic Information in Retrospective, Pooled Secondary Analysis in Clinically Low/ High-Risk Patients With HR+/HER2- EBC.

Journal: Clinical breast cancer

Published: June 04, 2025

Real-world data of CanAssist Breast- first immunohistochemistry and AI-based prognostic test.

Real-world data of CanAssist Breast- first immunohistochemistry and AI-based prognostic test.

Journal: Scientific reports

Published: March 05, 2025

CanAssist Breast-based prognostication in low-intermediate estrogen receptor positive (ER1%-20%) early-stage breast cancer patients helps guide treatment decisions.

CanAssist Breast-based prognostication in low-intermediate estrogen receptor positive (ER1%-20%) early-stage breast cancer patients helps guide treatment decisions.

Journal: Therapeutic advances in medical oncology

Published: December 13, 2024

Comparison of Risk Stratification by CanAssist Breast Test Performed on Core Needle Biopsies Versus Surgical Specimens in Hormone Receptor-Positive, Her2-Negative Early Breast Cancer.

Comparison of Risk Stratification by CanAssist Breast Test Performed on Core Needle Biopsies Versus Surgical Specimens in Hormone Receptor-Positive, Her2-Negative Early Breast Cancer.

Journal: Cureus

Published: September 22, 2024

The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment.

The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment.

Journal: Cancer medicine

Published: December 12, 2022

Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial.

Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial.

Journal: Breast cancer research : BCR

Published: December 01, 2022

A comparative analysis of recurrence risk predictions in ER+/HER2- early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast.

A comparative analysis of recurrence risk predictions in ER+/HER2- early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast.

Journal: Breast cancer research and treatment

Published: May 27, 2022

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort.

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort.

Journal: Breast (Edinburgh, Scotland)

Published: September 21, 2021

Validation of CanAssist Breast immunohistochemistry biomarkers on an automated platform and its applicability in tissue microarray.

Validation of CanAssist Breast immunohistochemistry biomarkers on an automated platform and its applicability in tissue microarray.

Journal: International journal of clinical and experimental pathology

Published: May 16, 2021

Suggestions to Make Health Technology Assessment in India an Efficient Process.

Suggestions to Make Health Technology Assessment in India an Efficient Process.

Journal: Value in health regional issues

Published: March 22, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026